LGND AI, Inc. | $9,000,000 | (Jul 11, 2025)
Cerebrium | $8,500,000 | (Jul 11, 2025)
Bilt | $250,000,000 | (Jul 11, 2025)
Certified by Founder
Lodge
Odyssey Therapeutics
start up
United States
- Boston, Massachusetts
- 06/12/2023
- Series C
- $101,000,000
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
- Industry Biotechnology Research
- Website https://www.odysseytx.com/
- LinkedIn https://www.linkedin.com/company/odyssey-tx/about/
Aqtual, Inc. | $31,000,000 | (Jul 11, 2025)
Knox Systems, Inc. | $6,500,000 | (Jul 11, 2025)
Live Story | $3,154,279 | (Jul 11, 2025)
Spacelift | $51,000,000 | (Jul 11, 2025)
Foundation EGI | $23,000,000 | (Jul 11, 2025)
Augmentus Robotics | $11,000,000 | (Jul 11, 2025)
Datafy.io | $20,000,000 | (Jul 11, 2025)
Renasant Bio | $54,500,000 | (Jul 11, 2025)
Supply Wisdom | $14,000,000 | (Jul 10, 2025)